Cargando…

Suppressing kidney angiotensinogen in blood pressure regulation

Detalles Bibliográficos
Autor principal:	Saigusa, Takamitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758934/ https://www.ncbi.nlm.nih.gov/pubmed/26847848 http://dx.doi.org/10.14814/phy2.12704

Ejemplares similares

Urinary angiotensinogen as a marker of elevated blood pressure in patients with chronic kidney disease
por: Jung, Chan-Young, et al.
Publicado: (2021)

Angiotensinogen and the Modulation of Blood Pressure
por: Shu, Zimei, et al.
Publicado: (2021)

Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes
por: Soltysiak, Jolanta, et al.
Publicado: (2014)

Angiotensinogen as a biomarker of acute kidney injury
por: Ba Aqeel, Sheeba Habeeb, et al.
Publicado: (2017)

Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure
por: Ye, Dien, et al.
Publicado: (2023)

The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules
por: Ohashi, Naro, et al.
Publicado: (2019)

Developmental Regulation of Angiotensinogen Gene Expression in Sheep
por: Olson, Ann Louise, et al.
Publicado: (1990)

Structure and functions of angiotensinogen
por: Lu, Hong, et al.
Publicado: (2016)

Angiotensinogen and interleukin 18 in serum and urine of children with kidney cysts
por: Plesiński, Krzysztof, et al.
Publicado: (2019)

Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022)

Heterogeneous Nuclear Ribonucleoprotein F Suppresses Angiotensinogen Gene Expression and Attenuates Hypertension and Kidney Injury in Diabetic Mice
por: Lo, Chao-Sheng, et al.
Publicado: (2012)

Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease
por: Cruz-López, Edwyn O., et al.
Publicado: (2022)

Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen
por: Uijl, Estrellita, et al.
Publicado: (2022)

Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease
por: Ishigaki, Sayaka, et al.
Publicado: (2021)

HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference
por: Bourgeois, Camille T., et al.
Publicado: (2017)

Effect of urinary angiotensinogen and high-salt diet on blood pressure in patients with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease (KNOW-CKD)
por: Kim, Ha Yeon, et al.
Publicado: (2021)

Correction: Corrigendum: Structure and functions of angiotensinogen
por: Lu, Hong, et al.
Publicado: (2016)

Angiotensinogen Gene Transcription in Pulmonary Fibrosis
por: Uhal, Bruce D., et al.
Publicado: (2012)

Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
por: Sun, Wei, et al.
Publicado: (2014)

Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease
por: Nishijima, Yoko, et al.
Publicado: (2014)

Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Study
por: Suh, Sang Heon, et al.
Publicado: (2022)

Adipocytes do not significantly contribute to plasma angiotensinogen
por: Koizumi, Masahiro, et al.
Publicado: (2016)

Urinary Angiotensinogen as a Biomarker of Nephropathy in Childhood
por: Urushihara, Maki, et al.
Publicado: (2011)

Angiotensinogen Variants among Resistant Hypertensive Patients
por: Barbaro, Natalia Ruggeri, et al.
Publicado: (2014)

Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus
por: Lee, Min Jin, et al.
Publicado: (2017)

Serum and urinary angiotensinogen levels as prognostic indicators in acute kidney injury: a prospective study
por: Akin, Ali, et al.
Publicado: (2023)

Possible role for glomerular-derived angiotensinogen in nephrotic syndrome
por: Yamazaki, Mihoko, et al.
Publicado: (2016)

A redox switch in angiotensinogen modulates angiotensin release
por: Zhou, Aiwu, et al.
Publicado: (2010)

Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014)

Structural basis for the specificity of renin-mediated angiotensinogen cleavage
por: Carrell, Robin W., et al.
Publicado: (2019)

Urinary excretion of renin and angiotensinogen in hypertensive children and adolescents
por: Zając, Magdalena, et al.
Publicado: (2019)

Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
por: Valias, Gabriela Ribeiro, et al.
Publicado: (2022)

Genetic Polymorphism in Angiotensinogen and Its Association with Cardiometabolic Diseases
por: Shahid, Momina, et al.
Publicado: (2022)

Urinary angiotensinogen predicts adverse outcomes among acute kidney injury patients in the intensive care unit
por: Alge, Joseph L, et al.
Publicado: (2013)

Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
por: Park, Hayne Cho, et al.
Publicado: (2020)

What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease?
por: Aronow, Wilbert S.
Publicado: (2012)

Blood pressure measurement in patients with chronic kidney disease: from clinical trial to clinical practice
por: Kim, Il Young, et al.
Publicado: (2019)

Detailed Localization of Augmented Angiotensinogen mRNA and Protein in Proximal Tubule Segments of Diabetic Kidneys in Rats and Humans
por: Kamiyama, Masumi, et al.
Publicado: (2014)

Effect of unilateral nephrectomy on urinary angiotensinogen levels in living kidney donors: 1 year follow-up study
por: Kendi Celebi, Zeynep, et al.
Publicado: (2017)

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA
por: Ranasinghe, Priyanga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sqif0mp2po6cf6tr57aoim8j2n